References
1 Klein I, Danzi S. Thyroid disease and the heart. Curr Probl Cardiol. 2016. February; 41 2: 65– 92.
2 Biondi B. Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol. 2012. November; 167 5: 609– 18
3 Dahl P, Danzi S, Klein I. Thyrotoxic cardiac disease. Curr Heart Fail Rep. 2008;5:170–176.
4 Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006;35:663–686.
5 Greyson CR. Pathophysiology of right ventricular failure. Crit Care Med. 2008; 36(1 Suppl):S57–S65
6 Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short‐term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014; 64:1407–1415.
7 Imamura T, Kinugawa K, Kinoshita O, Nawata K, Ono M: High pulmonary vascular resistance in addition to low right ventricular stroke work index effectively predicts biventricular assist device requirement. J Artif Organs 2016; 19(1): 44–53.
8 Drazner M.H., Velez-Martinez M., Ayers C.R., et al. Relationship of right- to left-sided ventricular filling pressures in advanced heart failure: insights from the ESCAPE trial. Circ Heart Fail. 2013; 6:264–270.
9 Kuchibhotla S, Esposito ML, Breton C, et al. Acute biventricular mechanical circulatory support for cardiogenic shock. J Am Heart Assoc. 2017;6:e006670.
10 Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 2015; 34:1549–1560.